Recursion (RXRX) Fundamental Analysis: Revenue, Earnings & Valuation

3.37 / 10

Netural

Fundamental rating is neutral, with an overall score of 3.4/10. Revenue‑to‑market value is negative, profit‑to‑market modestly positive, cash‑to‑market flat, and inventory turnover decent. However, current and fixed asset turnovers are low, gross margin is weak, and cost‑of‑sales ratio is high, indicating challenging fundamentals.

Analysis Checks(5/10)

Revenue-MV

Value-1.81

Score2/3

Weight22.63%

1M Return8.05%

Inventory turnover ratio

Value106.57

Score3/3

Weight19.58%

1M Return6.65%

Gross profit margin (%)

Value4.99

Score1/3

Weight0.76%

1M Return0.36%

Profit-MV

Value0.68

Score2/3

Weight18.42%

1M Return6.36%

Income tax / Total profit (%)

Value0.02

Score2/3

Weight2.31%

1M Return0.98%

Current assets turnover ratio

Value0.10

Score0/3

Weight-3.44%

1M Return-1.61%

Fixed assets turnover ratio

Value0.37

Score1/3

Weight-2.40%

1M Return-1.13%

Cost of sales ratio (%)

Value95.01

Score1/3

Weight-12.54%

1M Return-7.30%

Asset-MV

Value-0.55

Score1/3

Weight36.63%

1M Return11.48%

Cash-MV

Value0.03

Score2/3

Weight18.04%

1M Return6.19%

Is RXRX undervalued or overvalued?

RXRX scores 3.37/10 on fundamentals and holds a Fair valuation at present. Backed by its -59.54% ROE, -863.35% net margin, -2.40 P/E ratio, 1.37 P/B ratio, and 14.79% earnings growth, these metrics solidify its Netural investment rating.